Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kyoto University, Graduate School of Medicine
Obstructive sleep apnea (OSA) and hypertension have a significant interrelationship, and both disorders are well known risk factors for cardiovascular diseases (CVD). Treating them appropriately may improve the prognosis of the patients. Presently, continuous positive airway pressure (CPAP) therapy is the first-line therapy for OSA, and angiotensin II receptor blockers and long-acting calcium channel blockers for hypertension in Japan. Therefore, in the present study, we wanted to compare the effects of these different types of antihypertensive drugs on the control of blood pressure in patients with OSA whose hypertension is not controlled well after CPAP therapy.
Age
20–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Apnea and hypopnea index of more than 20 /hr, and treated with CPAP
Uncontrolled hypertension (defined as systolic blood pressure of more than 130 mmHg or diastolic blood pressure of more than 80 mmHg
You may not be if
Cerebrovascular diseases, myocardial infarction, angina pectoris or heart failure within 6 months
Uncontrolled arrhythmia
Severe hepatic or renal disorders
Having poor prognosis disorders such as malignant disorders